Novo Nordisk's Diabetes Pill Gets EU Label Extension For Heart Benefits
诺和诺德(US:NVO) WSJ·2025-09-15 20:43Rybelsus is approved to treat type 2 diabetes but can now officially list its heart benefits as well. ...
诺和诺德(US:NVO) WSJ·2025-09-15 20:43
诺和诺德(US:NVO) WSJ·2025-09-15 20:43